163 related articles for article (PubMed ID: 38425769)
1. Cancer medicines: a private vice for public benefit?
Sullivan R
Ecancermedicalscience; 2024; 18():ed131. PubMed ID: 38425769
[TBL] [Abstract][Full Text] [Related]
2. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia.
Abrha S; Tadesse E; Atey TM; Molla F; Melkam W; Masresha B; Gashaw S; Wondimu A
BMC Pregnancy Childbirth; 2018 Nov; 18(1):464. PubMed ID: 30497441
[TBL] [Abstract][Full Text] [Related]
5. Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country.
Moye-Holz D; van Dijk JP; Reijneveld SA; Hogerzeil HV
Global Health; 2017 Aug; 13(1):53. PubMed ID: 28764738
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
Ocran Mattila P; Biritwum RB; Babar ZU
PLoS One; 2023; 18(5):e0279817. PubMed ID: 37134123
[TBL] [Abstract][Full Text] [Related]
7. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology.
Sisay M; Amare F; Hagos B; Edessa D
J Pharm Policy Pract; 2021 Jul; 14(1):57. PubMed ID: 34225781
[TBL] [Abstract][Full Text] [Related]
8. Price, Availability, and Affordability of Antineoplastic Medicines in Harare's Public and Private Institutions: Implication for Access.
Mutyavaviri SN; Mensah KB; Marume A; Boamah Mensah AB; Bangalee V
Value Health Reg Issues; 2021 Sep; 25():118-125. PubMed ID: 33965656
[TBL] [Abstract][Full Text] [Related]
9. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y; Wang Y; Sun X; Li X
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
[TBL] [Abstract][Full Text] [Related]
10. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
[TBL] [Abstract][Full Text] [Related]
11. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
12. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
[TBL] [Abstract][Full Text] [Related]
13. Availability, prices and affordability of selected essential medicines in Jordan: a national survey.
Alefan Q; Amairi R; Tawalbeh S
BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486
[TBL] [Abstract][Full Text] [Related]
14. Implementation of medicines pricing policies in sub-Saharan Africa: systematic review.
Koduah A; Baatiema L; de Chavez AC; Danso-Appiah A; Kretchy IA; Agyepong IA; King N; Ensor T; Mirzoev T
Syst Rev; 2022 Dec; 11(1):257. PubMed ID: 36457058
[TBL] [Abstract][Full Text] [Related]
15. Prices, availability and affordability of medicines in Rwanda.
Bizimana T; Kayumba PC; Heide L
PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
[TBL] [Abstract][Full Text] [Related]
16. Implications of national tax policy on local pharmaceutical production in a southwestern state nigeria - qualitative research for the intersection of national pharmaceutical policy on health systems development.
Obembe TA; Adenipekun AB; Morakinyo OM; Odebunmi KO
BMC Health Serv Res; 2022 Feb; 22(1):264. PubMed ID: 35220971
[TBL] [Abstract][Full Text] [Related]
17. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
[TBL] [Abstract][Full Text] [Related]
18. Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology.
Kasonde L; Tordrup D; Naheed A; Zeng W; Ahmed S; Babar ZU
BMC Health Serv Res; 2019 Jun; 19(1):383. PubMed ID: 31196078
[TBL] [Abstract][Full Text] [Related]
19. Delivering affordable cancer care in high-income countries.
Sullivan R; Peppercorn J; Sikora K; Zalcberg J; Meropol NJ; Amir E; Khayat D; Boyle P; Autier P; Tannock IF; Fojo T; Siderov J; Williamson S; Camporesi S; McVie JG; Purushotham AD; Naredi P; Eggermont A; Brennan MF; Steinberg ML; De Ridder M; McCloskey SA; Verellen D; Roberts T; Storme G; Hicks RJ; Ell PJ; Hirsch BR; Carbone DP; Schulman KA; Catchpole P; Taylor D; Geissler J; Brinker NG; Meltzer D; Kerr D; Aapro M
Lancet Oncol; 2011 Sep; 12(10):933-80. PubMed ID: 21958503
[TBL] [Abstract][Full Text] [Related]
20. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
Todesco B; Ostuzzi G; Barbui C
Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]